Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
26 Apr 24
8-K
Results of Operations and Financial Condition
25 Apr 24
DEF 14C
Information statement
13 Mar 24
10-K
2023 FY
Annual report
23 Feb 24
8-K
Federated Hermes, Inc. reports fourth quarter and full-year 2023 earnings
25 Jan 24
8-K
Departure of Directors or Certain Officers
15 Dec 23
10-Q
2023 Q3
Quarterly report
27 Oct 23
8-K
Federated Hermes, Inc. reports third quarter 2023 earnings
26 Oct 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Federated Hermes, Inc. reports second quarter 2023 earnings
27 Jul 23
10-Q
2023 Q1
Quarterly report
2 May 23
8-K
Federated Hermes, Inc. reports first quarter 2023 earnings
27 Apr 23
DEF 14C
Information statement
15 Mar 23
10-K
2022 FY
Annual report
24 Feb 23
8-K
Federated Hermes, Inc. reports fourth quarter and full-year 2022 earnings
26 Jan 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
8-K
Federated Hermes, Inc. reports third quarter 2022 earnings
27 Oct 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
8-K
Federated Hermes, Inc. reports second quarter 2022 earnings
28 Jul 22
8-K
Entry into a Material Definitive Agreement
18 Jul 22
8-K
Other Events
7 Jun 22
10-Q
2022 Q1
Quarterly report
3 May 22
8-K
Federated Hermes, Inc. reports first quarter 2022 earnings
28 Apr 22
8-K
Entry into a Material Definitive Agreement
17 Mar 22
DEF 14C
Information statement
16 Mar 22
8-K
Other Events
14 Mar 22
10-K
2021 FY
Annual report
25 Feb 22
8-K
Federated Hermes, Inc. reports fourth quarter and full-year 2021 earnings
27 Jan 22
S-8
Registration of securities for employees
10 Jan 22
8-K
Departure of Directors or Certain Officers
7 Jan 22
DEF 14C
Information statement
17 Dec 21
8-K
Other Events
15 Dec 21
10-Q
2021 Q3
Quarterly report
29 Oct 21
8-K
Federated Hermes, Inc. reports third quarter 2021 earnings
28 Oct 21
8-K
Other Events
31 Aug 21
8-K
Federated Hermes, Inc. to acquire remaining interest in Hermes Investment Management held by BT Pension Scheme
18 Aug 21
10-Q
2021 Q2
Quarterly report
3 Aug 21
8-K
Entry into a Material Definitive Agreement
30 Jul 21
8-K
Federated Hermes, Inc. reports second quarter 2021 earnings
29 Jul 21
10-Q
2021 Q1
Quarterly report
4 May 21
Latest ownership filings
3
Karen Hanlon
25 Apr 24
4
Gordon J Ceresino
9 Apr 24
SC 13G/A
Fusion Pharmaceuticals Inc.
8 Apr 24
SC 13D
Fusion Pharmaceuticals Inc.
25 Mar 24
SC 13G/A
VANGUARD GROUP INC
11 Mar 24
4
THOMAS R DONAHUE
7 Mar 24
4
Peter J Germain
7 Mar 24
4
Meter Stephen Van
7 Mar 24
4
Paul A Uhlman
7 Mar 24
4
Saker Anwar Nusseibeh
7 Mar 24
4
Richard A Novak
7 Mar 24
4
J CHRISTOPHER DONAHUE
7 Mar 24
4
Dolores D Dudiak
7 Mar 24
SC 13G/A
Merus N.V.
6 Mar 24
SC 13G/A
Amphastar Pharmaceuticals, Inc.
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
FMR LLC
9 Feb 24
4
Paul A Uhlman
8 Feb 24
144
Notice of proposed sale of securities
7 Feb 24
SC 13G/A
P10, Inc.
7 Feb 24
13F-HR
Quarterly holdings report by institutional manager
31 Jan 24
4
Meter Stephen Van
30 Jan 24
144
Notice of proposed sale of securities
30 Jan 24
SC 13G/A
BlackRock Inc.
25 Jan 24
SC 13G/A
SOUNDTHINKING, INC.
18 Jan 24
SC 13G/A
SCYNEXIS INC
18 Jan 24
SC 13G/A
Rezolute, Inc.
18 Jan 24
SC 13G/A
Regulus Therapeutics Inc.
18 Jan 24
SC 13G/A
P10, Inc.
18 Jan 24
SC 13G/A
Minerva Neurosciences, Inc.
18 Jan 24
SC 13G/A
Merus N.V.
18 Jan 24
SC 13G/A
aTYR PHARMA INC
18 Jan 24
SC 13G/A
IDEAYA Biosciences, Inc.
18 Jan 24
SC 13G/A
Fusion Pharmaceuticals Inc.
18 Jan 24
SC 13G/A
DYNAVAX TECHNOLOGIES CORP
18 Jan 24